https://orcid.org/0000-0003-4103-2837
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet & David Bloom. (2022) Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Bruce Cm Wang, Nathorn Chaiyakunapruk, Shuiqing Zhu, Joseph B. Babigumira, Wesley Furnback, Ramaa Chitale, Amgad Gamil, Kun Zhao & Matt Wasserman. (2022) A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019). Expert Review of Vaccines 21:7, pages 885-898.
Read now
Read now
Johnna Perdrizet, Raymond A. Farkouh, Emily K. Horn, Kyla Hayford, Heather L. Sings & Matt D. Wasserman. (2022) The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Review of Vaccines 21:4, pages 499-511.
Read now
Read now
Hye-Young Kim, Seong-Beom Park, Eun-Sil Kang, Sang-Min Lee, Hyun-Jin Kim & Matt Wasserman. (2021) Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea. Human Vaccines & Immunotherapeutics 17:3, pages 909-918.
Read now
Read now
Tianyan Hu, Thomas Weiss, Goran Bencina, Kwame Owusu-Edusei & Tanaz Petigara. (2021) Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries. Journal of Medical Economics 24:1, pages 1098-1107.
Read now
Read now
Articles from other publishers (11)
Kris Doggen, Albert Jan van Hoek & Jeroen Luyten. (2023) Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella. PharmacoEconomics 41:5, pages 481-497.
Crossref
Crossref
M. Sakil Syeed, Priyanka Ghule, Lan M. Le, Sajesh K. Veettil, Emily K. Horn, Johnna Perdrizet, Matt Wasserman, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2023) Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health 26:4, pages 598-611.
Crossref
Crossref
Mariska M. J. Scheffer, Luc E. Coffeng & James F. O’Mahony. (2023) Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: a systematic review. International Journal of Technology Assessment in Health Care 39:1.
Crossref
Crossref
Elisa Barbieri, Gloria Porcu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti & Carlo Giaquinto. (2022) The Economic Burden of Pneumococcal Disease in Children: A Population-Based Investigation in the Veneto Region of Italy. Children 9:9, pages 1347.
Crossref
Crossref
Alessandra Løchen & Roy M. Anderson. (2021) Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations. Clinical Microbiology and Infection 27:10, pages 1546-1557.
Crossref
Crossref
Ruth Chapman, Kelly Sutton, Desmond Dillon-Murphy, Shreeya Patel, Betsy Hilton, Ray Farkouh & Matt Wasserman. (2020) Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Vaccine 38:45, pages 7138-7145.
Crossref
Crossref
Filippo Ansaldi, Sarah Pugh, Daniela Amicizia, Roberto Di Virgilio, Cecilia Trucchi, Andrea Orsi, Alessandro Zollo & Giancarlo Icardi. (2020) Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy. Pathogens 9:2, pages 76.
Crossref
Crossref
Paola Marchisio, Barbara Bortone, Martina Ciarcià, Marco Antonio Motisi, Sara Torretta, Guido Castelli Gattinara, Marina Picca, Giuseppe Di Mauro, Marisa Bonino, Nicola Mansi, Alfonso Varricchio, Gian Luigi Marseglia, Fabio Cardinale, Alberto Villani & Elena Chiappini. (2019) Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics. Pediatric Infectious Disease Journal 38:12S, pages S22-S36.
Crossref
Crossref
Susanna Esposito & Nicola Principi. (2019) Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?. Future Microbiology 14:11, pages 921-923.
Crossref
Crossref
Michele R. Wilson, Matt Wasserman, Taj Jadavji, Maarten Postma, Marie-Claude Breton, Francois Peloquin, Stephanie R. Earnshaw, Cheryl McDade, Heather L. Sings & Raymond Farkouh. (2018) Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”. Infectious Diseases and Therapy 7:4, pages 539-543.
Crossref
Crossref
Michele Wilson, Matt Wasserman, Taj Jadavi, Maarten Postma, Marie-Claude Breton, Francois Peloquin, Stephanie Earnshaw, Cheryl McDade, Heather Sings & Raymond Farkouh. (2018) Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada. Infectious Diseases and Therapy 7:3, pages 353-371.
Crossref
Crossref